Tags

Type your tag names separated by a space and hit enter

[New therapeutic approaches in stroke prevention].
Rev Neurol. 2002 Nov 1-15; 35(9):801-4.RN

Abstract

Stroke is the second most common cause of death and dementia and the number one cause of serious disability in adults in developed countries. After the stroke there remains a maximum vascular risk of recurrence (stroke, heart attack or vascular death). The known vascular risk factors (RF) could only explain 50% of vascular events. A better knowledge of atherogenesis, of the mechanisms that cause instability in the atheroma plaque and of new vascular RF gives rise to new preventive therapeutic approaches. This knowledge is the result of new clinical trials, such as the use of ACE inhibitors, statins, vitamins related with homocysteine, and the use of antihypertensive drugs to prevent cognitive deterioration or dementia, which add to those that have already been conducted.

Authors

No affiliation info available

Pub Type(s)

Editorial
English Abstract

Language

spa

PubMed ID

12436374

Citation

Gil-Nuñez, A C.. "[New Therapeutic Approaches in Stroke Prevention]." Revista De Neurologia, vol. 35, no. 9, 2002, pp. 801-4.
Gil-Nuñez AC. [New therapeutic approaches in stroke prevention]. Rev Neurol. 2002;35(9):801-4.
Gil-Nuñez, A. C. (2002). [New therapeutic approaches in stroke prevention]. Revista De Neurologia, 35(9), 801-4.
Gil-Nuñez AC. [New Therapeutic Approaches in Stroke Prevention]. Rev Neurol. 2002 Nov 1-15;35(9):801-4. PubMed PMID: 12436374.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [New therapeutic approaches in stroke prevention]. A1 - Gil-Nuñez,A C, PY - 2002/11/19/pubmed PY - 2003/4/2/medline PY - 2002/11/19/entrez SP - 801 EP - 4 JF - Revista de neurologia JO - Rev Neurol VL - 35 IS - 9 N2 - Stroke is the second most common cause of death and dementia and the number one cause of serious disability in adults in developed countries. After the stroke there remains a maximum vascular risk of recurrence (stroke, heart attack or vascular death). The known vascular risk factors (RF) could only explain 50% of vascular events. A better knowledge of atherogenesis, of the mechanisms that cause instability in the atheroma plaque and of new vascular RF gives rise to new preventive therapeutic approaches. This knowledge is the result of new clinical trials, such as the use of ACE inhibitors, statins, vitamins related with homocysteine, and the use of antihypertensive drugs to prevent cognitive deterioration or dementia, which add to those that have already been conducted. SN - 0210-0010 UR - https://www.unboundmedicine.com/medline/citation/12436374/[New_therapeutic_approaches_in_stroke_prevention]_ L2 - http://www.revneurol.com/LinkOut/formMedLine.asp?Refer=2002448&Revista=Revneurol DB - PRIME DP - Unbound Medicine ER -